PL363960A1 - Pochodne oksazolidynonów jako środki przeciwbakteryjne - Google Patents

Pochodne oksazolidynonów jako środki przeciwbakteryjne

Info

Publication number
PL363960A1
PL363960A1 PL01363960A PL36396001A PL363960A1 PL 363960 A1 PL363960 A1 PL 363960A1 PL 01363960 A PL01363960 A PL 01363960A PL 36396001 A PL36396001 A PL 36396001A PL 363960 A1 PL363960 A1 PL 363960A1
Authority
PL
Poland
Prior art keywords
antimicrobials
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Application number
PL01363960A
Other languages
English (en)
Inventor
Anita Mehta
Sudershan K. Arora
Biswajit Das
Abhijit Ray
Sonali Rudra
Ashok Rattan
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL363960A1 publication Critical patent/PL363960A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL01363960A 2000-07-17 2001-07-16 Pochodne oksazolidynonów jako środki przeciwbakteryjne PL363960A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN654DE2000 2000-07-17
PCT/IB2001/001262 WO2002006278A1 (en) 2000-07-17 2001-07-16 Oxazolidinone derivatives as antimicrobials

Publications (1)

Publication Number Publication Date
PL363960A1 true PL363960A1 (pl) 2004-11-29

Family

ID=11097070

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01363960A PL363960A1 (pl) 2000-07-17 2001-07-16 Pochodne oksazolidynonów jako środki przeciwbakteryjne

Country Status (16)

Country Link
US (2) US6734307B2 (pl)
EP (1) EP1303511A1 (pl)
JP (1) JP2004504321A (pl)
CN (1) CN1447808A (pl)
AU (2) AU2001269370B2 (pl)
BR (1) BR0112826A (pl)
CA (1) CA2415965A1 (pl)
CZ (1) CZ2003228A3 (pl)
HU (1) HUP0302918A2 (pl)
MX (1) MXPA03000503A (pl)
NZ (1) NZ523700A (pl)
PL (1) PL363960A1 (pl)
RU (1) RU2292345C9 (pl)
SK (1) SK1402003A3 (pl)
WO (1) WO2002006278A1 (pl)
ZA (1) ZA200300471B (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
CZ2003228A3 (cs) 2000-07-17 2003-06-18 Ranbaxy Laboratories Limited Oxazolidinonové deriváty jako antimikrobiální látky
WO2003008389A1 (en) * 2001-07-16 2003-01-30 Ranbaxy Laboratories Limited Oxazolidinone derivatives as potential antimicrobials
JP2005503435A (ja) * 2001-04-17 2005-02-03 メルク アンド カンパニー インコーポレーテッド ビシクロ［３．１．０］ヘキサン含有オキサゾリジノン抗生物質及びその誘導体
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
FR2828488B1 (fr) 2001-08-08 2005-06-10 Oreal Composition pour la teinture de fibres keratiniques contenant une paraphenylenediamine substituee par un radical diazacycloheptane
AU2003231920A1 (en) * 2002-04-01 2003-10-13 Cadila Healthcare Limited Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
WO2003093247A2 (en) * 2002-04-30 2003-11-13 Orchid Chemicals & Pharmaceuticals Ltd Antibacterial agents
AU2003230076A1 (en) * 2002-05-15 2003-12-02 Ranbaxy Laboratories Limited Polymorphic forms of phenyl oxazolidinone derivatives
WO2003097640A1 (en) * 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
AU2002319848A1 (en) * 2002-07-29 2004-02-25 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
EP1578734A1 (en) * 2002-08-22 2005-09-28 Orchid Chemicals and Pharmaceuticals Ltd Novel antibacterial agents
AU2002339721A1 (en) 2002-09-20 2004-04-08 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
EP1594852A1 (en) * 2003-02-07 2005-11-16 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
EP1620433A1 (en) * 2003-04-07 2006-02-01 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
WO2005003087A2 (en) * 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
CA2530140C (en) * 2003-07-02 2010-11-09 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
JP2007521283A (ja) * 2003-07-02 2007-08-02 メルク アンド カンパニー インコーポレーテッド シクロプロピル基で置換されたオキサゾリジノン系抗生物質およびその誘導体
WO2005005399A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2005051933A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
WO2005082899A1 (en) * 2004-01-28 2005-09-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006040614A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited Substituted oxazolidinone derivatives
JP2008544979A (ja) 2005-06-29 2008-12-11 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌剤としてのホモモルホリンオキサゾリジノン
FR2895735B1 (fr) 2005-12-30 2008-04-18 Ecopack France Valve a poche amelioree
US7728031B2 (en) 2006-02-24 2010-06-01 Abbott Laboratories Octahydro-pyrrolo[3,4-b]pyrrole derivatives
CN103497173A (zh) 2006-03-31 2014-01-08 财团法人乙卯研究所 具有杂环的新化合物
CN101809021B (zh) 2007-09-11 2013-04-24 雅培制药有限公司 八氢-吡咯并[3,4-b]吡咯n-氧化物
JPWO2009044777A1 (ja) * 2007-10-02 2011-02-10 財団法人乙卯研究所 ７員ヘテロ環を有するオキサゾリジノン誘導体
WO2009132310A1 (en) * 2008-04-25 2009-10-29 Wisconsin Alumni Research Foundation Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
KR20130102614A (ko) 2010-11-03 2013-09-17 욱크하르트 리미티드 인산 모노-(1-[4-[(s)-5-(아세틸아미노메틸)-2-옥소-옥사졸리딘-3-일]-2,6-디플루오로페닐]-4-메톡시메틸피페리딘-4-일) 에스테르의 제조 방법
JP5796134B2 (ja) 2011-09-29 2015-10-21 山東軒竹医薬科技有限公司 ビアリールヘテロ環で置換されたオキサゾリドン抗菌薬
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
US10080757B2 (en) 2016-03-11 2018-09-25 Wisconsin Alumni Research Foundation Inhibitors of UDP-galactopyranose mutase
CN109020873B (zh) * 2018-07-16 2020-04-28 青岛农业大学 以靶标蛋白甾醇14α-脱甲基酶三维结构筛选的化合物及其在在制备杀菌剂中的应用
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
GEP20257772B (en) 2019-04-03 2025-06-10 Univ Emory Pyrrole compounds
KR102894590B1 (ko) 2020-06-18 2025-12-03 아카제라 메디신즈, 인크. 옥사졸리디논 화합물, 옥사졸리디논 화합물을 포함하는 리포좀 조성물 및 이의 사용 방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH613205A5 (pl) * 1975-06-06 1979-09-14 Hoffmann La Roche
US4921869A (en) 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE68918792T2 (de) 1988-09-15 1995-03-30 Upjohn Co 5-Indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(Nitrogen-substituierte)phenyl-5-beta-amidomethyloxazolidin-2-one.
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CA2119556C (en) 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
EP0730591B1 (en) 1993-11-22 1999-07-14 PHARMACIA & UPJOHN COMPANY Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
JPH11512429A (ja) * 1995-09-15 1999-10-26 ファルマシア・アンド・アップジョン・カンパニー アミノアリールオキサゾリジノン ｎ−オキシド
GB9521508D0 (en) * 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
GB9614238D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
CN1322204A (zh) 1998-11-27 2001-11-14 法玛西雅厄普约翰美国公司 具有硫代羰基官能团的噁唑烷酮抗菌剂
CZ2003228A3 (cs) 2000-07-17 2003-06-18 Ranbaxy Laboratories Limited Oxazolidinonové deriváty jako antimikrobiální látky

Also Published As

Publication number Publication date
HUP0302918A2 (hu) 2003-12-29
US20040242591A1 (en) 2004-12-02
WO2002006278A1 (en) 2002-01-24
US6734307B2 (en) 2004-05-11
RU2292345C2 (ru) 2007-01-27
NZ523700A (en) 2004-11-26
CZ2003228A3 (cs) 2003-06-18
MXPA03000503A (es) 2003-10-14
US20020103186A1 (en) 2002-08-01
JP2004504321A (ja) 2004-02-12
BR0112826A (pt) 2003-06-24
CA2415965A1 (en) 2002-01-24
AU2001269370B2 (en) 2005-10-27
EP1303511A1 (en) 2003-04-23
SK1402003A3 (en) 2003-08-05
ZA200300471B (en) 2003-10-29
CN1447808A (zh) 2003-10-08
RU2292345C9 (ru) 2007-05-10
AU6937001A (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AU6937001A (en) Oxazolidinone derivatives as antimicrobials
EG22695A (en) Novel phenyl-propargylether derivatives
AU6053701A (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
GB0029531D0 (en) Speed govenor
GB0017508D0 (en) Antimicrobials
GB0017031D0 (en) Antimicrobials
EP1542696A4 (en) OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIAL AGENTS
AU2002258054A1 (en) Oxazolidinone derivatives as antimicrobials
AU1397802A (en) Substituted c-cyclohexylmethylamine derivatives
PL356565A1 (pl) Pochodne aminosulfonylobifenylu
PL364873A1 (pl) Podstawione pochodne aminoetylo-fenylo-cykloheksanu
AU8993701A (en) Substituted 1-aminobutan-3-ol derivatives
GB0118407D0 (en) Oxazolidinone derivatives as antibacterial agents
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
AU4754001A (en) Novel benzosultam oxazolidinone antibacterial agents
IL155104A0 (en) 5-amino-1-pentene-3-ol substituted derivatives
EP1408955A4 (en) NEW METALLOTEXAPHYRINE DERIVATIVES
IL151598A0 (en) 2-phenylpyran-4-one derivatives
AU2002216086A1 (en) Isothiazolecarboxamides as microbicides
HK1055427A (en) Oxazolidinone derivatives as antimicrobials
GB0017275D0 (en) Antimicrobials
AU2002219458A1 (en) Oxazolidinone derivatives as potential antimicrobials
GB0021639D0 (en) Maurotoxin derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)